investment.com

Aktis Oncology, Inc. — insider transactions

19 transactions on record · AKTS · CIK 2035832

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
19
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
3
Bought, 3m
$0
Sold, 3m
$3.4M
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$861.7K
2026-07-08
Director share, 12m
47.4%
of transactions where role is stated
Current run
19 sells
consecutive same-direction transactions
Net 3m flow
-$3.4M
purchases minus sales
Total on record
19

Transactions

19 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-07-212026-07-201Herrmann KenDirectorExercise of derivative1,350$1.91$2.6Kfiling
2026-07-212026-07-201Herrmann KenDirectorExercise of derivative3,506$0.00—filing
2026-07-212026-07-201Herrmann KenDirectorExercise of derivative3,506$0.08$280.5filing
2026-07-212026-07-201Herrmann KenDirectorOpen market sale1,350$24.56$33.2Kfiling
2026-07-212026-07-201Herrmann KenDirectorOpen market sale3,506$24.56$86.1Kfiling
2026-07-212026-07-201Herrmann KenDirectorExercise of derivative1,350$0.00—filing
2026-07-202026-07-173Herrmann KenDirectorExercise of derivative3,065$0.00—filing
2026-07-202026-07-173Herrmann KenDirectorExercise of derivative3,065$0.08$245.2filing
2026-07-202026-07-173Herrmann KenDirectorOpen market sale3,065$25.21$77.3Kfiling
2026-07-102026-07-082Czibere AkosChief Medical OfficerOpen market sale14,800$27.13$401.5Kfiling
2026-07-102026-07-082Czibere AkosChief Medical OfficerExercise of derivative50,000$0.00—filing
2026-07-102026-07-082Ron-Bigger ShulamitChief Operating OfficerOpen market sale30,000$27.94$838.1Kfiling
2026-07-102026-07-082Czibere AkosChief Medical OfficerExercise of derivative50,000$4.95$247.5Kfiling
2026-07-102026-07-082Czibere AkosChief Medical OfficerOpen market sale4,371$28.71$125.5Kfiling
2026-07-102026-07-082Ron-Bigger ShulamitChief Operating OfficerOpen market sale15,800$27.13$428.7Kfiling
2026-07-102026-07-082Ron-Bigger ShulamitChief Operating OfficerExercise of derivative50,000$0.00—filing
2026-07-102026-07-082Czibere AkosChief Medical OfficerOpen market sale30,829$27.95$861.7Kfiling
2026-07-102026-07-082Ron-Bigger ShulamitChief Operating OfficerExercise of derivative50,000$3.66$183Kfiling
2026-07-102026-07-082Ron-Bigger ShulamitChief Operating OfficerOpen market sale4,200$28.75$120.7Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR

Aktis Oncology, Inc. insider transactions — 19 filings on record — investment.com